ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

136 hedge funds and large institutions have $261M invested in Zentalis Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 35 closing their positions.

Holders
136
Holders Change
-9
Holders Change %
-6.21%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
45
Reduced
40
Closed
35
Calls
$352K
Puts
$431K
Net Calls
-$79K
Net Calls Change
-$293K

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$3.56M
2
AC
2
Almitas Capital
California
$3.54M
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$5.54M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$4.15M
5
Millennium Management
5
Millennium Management
New York
$3.26M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$18.7M
2
State Street
2
State Street
Massachusetts
$4.59M
3
Citadel Advisors
3
Citadel Advisors
Florida
$10M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$17M
Name Market Value Shares Shares
Change 		Shares
Change %
MCMC
1
Matrix Capital Management Company
New Hampshire
$51.4M 13,959,973 – –
EAM
2
Eventide Asset Management
Massachusetts
$31.5M 8,547,896 – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$18.7M 5,075,837 -3,600,886 -42%
BlackRock
4
BlackRock
New York
$17.5M 4,761,173 -57,373 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$17M 4,612,707 -1,042,050 -18%
DC
6
Decheng Capital
California
$11.4M 3,108,095 +37,653 +1%
Citadel Advisors
7
Citadel Advisors
Florida
$10M 2,717,521 -1,785,392 -40%
Morgan Stanley
8
Morgan Stanley
New York
$5.93M 1,611,567 -339,155 -17%
Verition Fund Management
9
Verition Fund Management
Connecticut
$5.54M 1,504,320 +951,500 +172%
Primecap Management
10
Primecap Management
California
$5.51M 1,498,030 +265,690 +22%
MB
11
MPM BioImpact
Massachusetts
$5.39M 1,465,801 +15,801 +1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.76M 1,292,100 -42,359 -3%
State Street
13
State Street
Massachusetts
$4.59M 1,246,613 -1,805,779 -59%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$4.23M 1,149,400 +352,500 +44%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$4.15M 1,128,577 +888,236 +370%
WP
16
Woodline Partners
California
$3.88M 1,055,282 -461,795 -30%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$3.82M 1,036,911 +113,010 +12%
OM
18
Opaleye Management
Massachusetts
$3.56M 967,000 +967,000 New
TCM
19
Tybourne Capital Management
Hong Kong
$3.54M 961,486 – –
AC
20
Almitas Capital
California
$3.54M 960,928 +960,928 New
Two Sigma Investments
21
Two Sigma Investments
New York
$3.34M 908,601 -143,797 -14%
Millennium Management
22
Millennium Management
New York
$3.26M 886,086 +493,478 +126%
Bank of America
23
Bank of America
North Carolina
$2.85M 775,536 +267,303 +53%
Goldman Sachs
24
Goldman Sachs
New York
$2.33M 634,064 +14,811 +2%
GCP
25
GSA Capital Partners
United Kingdom
$2.24M 608,585 +353,384 +138%
1
2 3 4 5